These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 10382955
1. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation. Ibisch C, Gallot G, Vivien R, Diez E, Jotereau F, Garand R, Vié H. Bone Marrow Transplant; 1999 Jun; 23(11):1153-9. PubMed ID: 10382955 [Abstract] [Full Text] [Related]
2. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets. Gaschet J, Gallot G, Ibisch C, Lim A, Even J, Vivien R, Hallet MM, Milpied N, Vié H. Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075 [Abstract] [Full Text] [Related]
3. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy. Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y. Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020 [Abstract] [Full Text] [Related]
4. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon. Faber LM, van Luxemburg-Heijs SA, Rijnbeek M, Willemze R, Falkenburg JH. Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352 [Abstract] [Full Text] [Related]
5. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Rutten CE, van Luxemburg-Heijs SA, Griffioen M, Marijt EW, Jedema I, Heemskerk MH, Posthuma EF, Willemze R, Falkenburg JH. Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406 [Abstract] [Full Text] [Related]
6. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. Gaschet J, Lim A, Liem L, Vivien R, Hallet MM, Harousseau JL, Even J, Goulmy E, Bonneville M, Milpied N, Vié H. J Clin Invest; 1996 Jul 01; 98(1):100-7. PubMed ID: 8690780 [Abstract] [Full Text] [Related]
7. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1. Kasai M, Akatsuka Y, Emi N, Taji H, Kohno A, Abe A, Tanimoto M, Kodera Y, Saito H. Int J Hematol; 1999 Feb 01; 69(2):112-8. PubMed ID: 10071461 [Abstract] [Full Text] [Related]
8. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. Faber LM, van der Hoeven J, Goulmy E, Hooftman-den Otter AL, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH. J Clin Invest; 1995 Aug 01; 96(2):877-83. PubMed ID: 7635982 [Abstract] [Full Text] [Related]
9. Variability of the alloreactive T-cell response to human leukemic blasts. Delain M, Tiberghien P, Racadot E, Billot M, Pariset J, Chabod J, Cahn JY, Hervé P. Leukemia; 1994 Apr 01; 8(4):642-7. PubMed ID: 8152258 [Abstract] [Full Text] [Related]
10. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y, Japan Marrow Donor Program. Biol Blood Marrow Transplant; 2007 Mar 01; 13(3):315-28. PubMed ID: 17317585 [Abstract] [Full Text] [Related]
11. Differences in specificity of "DPw2-specific" cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones. Sánchez Pérez M, Diez Orejas R, Petersen JW, De Mars R, Shaw S. Eur J Immunol; 1990 Mar 01; 20(3):673-81. PubMed ID: 2108045 [Abstract] [Full Text] [Related]
12. Alloreactive feature of HLA-DP-specific cytotoxic T-cell clone. Nishimura M, Mitsunaga S, Akaza T, Mitomi Y, Tadokoro K, Juji T. Cell Immunol; 1994 Jan 01; 153(1):262-70. PubMed ID: 7904540 [Abstract] [Full Text] [Related]
13. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro]. Gu WY, Cao XS, Qiu GQ, Chen ZX, Sheng LX, Xie XB, He J, Cen JN, Shen HL. Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3475-80. PubMed ID: 16686063 [Abstract] [Full Text] [Related]
14. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M. Cancer Res; 2002 May 15; 62(10):2861-8. PubMed ID: 12019165 [Abstract] [Full Text] [Related]
15. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro]. Gu WY, Chen ZX, Qiu GQ, Hu SY, Jia L, Wu W, He J, Cen JN, He B. Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3401-6. PubMed ID: 19159569 [Abstract] [Full Text] [Related]
16. In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. van Lochem E, de Gast B, Goulmy E. Bone Marrow Transplant; 1992 Aug 30; 10(2):181-3. PubMed ID: 1525608 [Abstract] [Full Text] [Related]
17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA. Dan Med Bull; 2002 May 30; 49(2):89-108. PubMed ID: 12064093 [Abstract] [Full Text] [Related]
18. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. Jacobson S, Richert JR, Biddison WE, Satinsky A, Hartzman RJ, McFarland HF. J Immunol; 1984 Aug 30; 133(2):754-7. PubMed ID: 6203977 [Abstract] [Full Text] [Related]
19. Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia. Montagna D, Aricò M, Montini E, De Benedetti F, Maccario R. Cancer Res; 1995 Sep 01; 55(17):3835-9. PubMed ID: 7641201 [Abstract] [Full Text] [Related]
20. HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Herr W, Eichinger Y, Beshay J, Bloetz A, Vatter S, Mirbeth C, Distler E, Hartwig UF, Thomas S. Leukemia; 2017 Feb 01; 31(2):434-445. PubMed ID: 27479183 [Abstract] [Full Text] [Related] Page: [Next] [New Search]